Targeting both wild-type EGFR and its drug-resistant mutants with erlotinib-aptamer conjugates

Yan Li(Shandong Normal University), Songbo Xie(Tianjin Medical University Eye Hospital), Jun Zhou(Nankai University), Sijin Wu(Xi’an Jiaotong-Liverpool University), Ping Zhou(Shandong Normal University), Ruixin Ge(Shandong Normal University), Xiangrui Luo(Shandong Normal University), Miao Chen(ShanghaiTech University), Wei Pan(Shandong Normal University), Fan Zhang(Shandong Normal University), Jingrui Li(Shandong University of Technology), Jian H. Song(The University of Texas MD Anderson Cancer Center), Xifeng Dong(Tongji Hospital)
European Journal of Medicinal Chemistry
June 14, 2025
Cited by 6


Related Papers